Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinatedpyrimidine-based colorectal cancer chemotherapy-induced oral mucositis - Matsuda, C; Munemoto, Y; Mishima, H (Cancer Chemother Pharmacol, 2015)